In vivo monitoring of cellular energy metabolism using SoNar, a highly responsive sensor for NAD(+)/NADH redox state
Medicine didn't have a framework for 'intracellular redox balance' as a treatment target, so glutathione remained a laboratory molecule rather than a therapeutic tool
The recent SELECT trial demonstrated that semaglutide 2.4 mg (weight management dose) reduced MACE in patients with established cardiovascular disease
doi: 10.1038/nrg2072 100 ShiodaTManikkamMTraceyRGuerrero-BosagnaCSkinnerMK
Alcohol also dehydrates you and impairs the glucose regulation that tirzepatide supports, making it counterproductive for weight loss
[DOI] [PubMed] [Google Scholar] 29.Fulghesu AM, Ciampelli M, Muzj G, Belosi C, Selvaggi L, Ayala GF, et al